Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
0001193125-19-195674.pdf 0001193125-19-195674.rtf 0001193125-19-195674.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-019205.pdf 0000899243-19-019205.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-018444.pdf 0000899243-19-018444.rtf View HTML

Official notification to shareholders of matters to be brought to a vote ("Proxy")

DEF 14A
Proxy Filings
0001193125-19-174854.pdf 0001193125-19-174854.rtf 0001193125-19-174854.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-19-016870.pdf 0000899243-19-016870.rtf View HTML

A preliminary proxy statement providing notification matters to be brought to a vote

PRE 14A
Proxy Filings
0001193125-19-168295.pdf 0001193125-19-168295.rtf 0001193125-19-168295.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0000899243-19-015636.pdf 0000899243-19-015636.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-19-158360.pdf 0001193125-19-158360.rtf 0001193125-19-158360.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capita 0000919574-19-003369.pdf 0000919574-19-003369.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Cukier Herm 0000899243-19-013104.pdf 0000899243-19-013104.rtf View HTML

Copyright Morningstar

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon